newsfilter
← Latest News
GlobeNewswire·

Galera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., May 04, 2023 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (NASDAQ:GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics